Access to new direct‐acting antiviral agents against HCV infection: A view from Spain

Publisher： John Wiley & Sons Inc

E-ISSN： 2046-2484|5|1|22-23

ISSN： 2046-2484

Source： CLINICAL LIVER DISEASE (ELECTRONIC), Vol.5, Iss.1, 2015-01, pp. : 22-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is the ethical responsibility of a provider when prescribing the new direct‐acting antiviral agents to patients with hepatitis C infection?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 5, 2015-11 ,pp. : 117-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

The dawn of a new era in the treatment of HCV infection: A view from the USA

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 4, Iss. 5, 2014-11 ,pp. : 107-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

New treatments for HCV: Perspective from Asia

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 1, 2015-01 ,pp. : 17-21

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treating HCV infection in children

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 1, 2015-01 ,pp. : 14-16

John Wiley & Sons Inc

Access to resources Recommend Favorite

Herbicidal agents from actinomycetes against selected crop plants and weeds

By Dhanasekaran Dharumadurai  

Natural Product Research, Vol. 24, Iss. 6, 2010-04 ,pp. : 521-529

Taylor & Francis Ltd

Access to resources Recommend Favorite